[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Clinical Biomarker Testing Market - Global Outlook and Forecast 2021-2027

April 2021 | 91 pages | ID: CEC403EA8211EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Clinical Biomarker Testing in Global, including the following market information:

Global Clinical Biomarker Testing Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Clinical Biomarker Testing market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Clinical Biomarker Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Clinical Biomarker Testing Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Clinical Biomarker Testing Market Segment Percentages, By Type, 2020 (%)
  • Cancer
  • Metabolism
  • Infectious Disease
  • Cardiology
  • Neurology
  • Immunological Disease
China Clinical Biomarker Testing Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Clinical Biomarker Testing Market Segment Percentages, By Application, 2020 (%)
  • Drug Discovery
  • Nutrigenomics
  • Toxicology Testing
  • Personalized Medicine
  • Functional Genomics
Global Clinical Biomarker Testing Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Clinical Biomarker Testing Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Clinical Biomarker Testing Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Clinical Biomarker Testing Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Abbott Laboratories
  • AbbVie Inc.
  • Adaptive Biotechnologies
  • Agilent Technologies
  • BD
  • Becton Dickinson
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Merck and Co.
  • Thermofisher Scientific
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Clinical Biomarker Testing Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Clinical Biomarker Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CLINICAL BIOMARKER TESTING OVERALL MARKET SIZE

2.1 Global Clinical Biomarker Testing Market Size: 2021 VS 2027
2.2 Global Clinical Biomarker Testing Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Clinical Biomarker Testing Players in Global Market
3.2 Top Global Clinical Biomarker Testing Companies Ranked by Revenue
3.3 Global Clinical Biomarker Testing Revenue by Companies
3.4 Top 3 and Top 5 Clinical Biomarker Testing Companies in Global Market, by Revenue in 2020
3.5 Global Companies Clinical Biomarker Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Clinical Biomarker Testing Players in Global Market
  3.6.1 List of Global Tier 1 Clinical Biomarker Testing Companies
  3.6.2 List of Global Tier 2 and Tier 3 Clinical Biomarker Testing Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Clinical Biomarker Testing Market Size Markets, 2021 & 2027
  4.1.2 Cancer
  4.1.3 Metabolism
  4.1.4 Infectious Disease
  4.1.5 Cardiology
  4.1.6 Neurology
  4.1.7 Immunological Disease
4.2 By Type - Global Clinical Biomarker Testing Revenue & Forecasts
  4.2.1 By Type - Global Clinical Biomarker Testing Revenue, 2016-2021
  4.2.2 By Type - Global Clinical Biomarker Testing Revenue, 2022-2027
  4.2.3 By Type - Global Clinical Biomarker Testing Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Clinical Biomarker Testing Market Size, 2021 & 2027
  5.1.2 Drug Discovery
  5.1.3 Nutrigenomics
  5.1.4 Toxicology Testing
  5.1.5 Personalized Medicine
  5.1.6 Functional Genomics
5.2 By Application - Global Clinical Biomarker Testing Revenue & Forecasts
  5.2.1 By Application - Global Clinical Biomarker Testing Revenue, 2016-2021
  5.2.2 By Application - Global Clinical Biomarker Testing Revenue, 2022-2027
  5.2.3 By Application - Global Clinical Biomarker Testing Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Clinical Biomarker Testing Market Size, 2021 & 2027
6.2 By Region - Global Clinical Biomarker Testing Revenue & Forecasts
  6.2.1 By Region - Global Clinical Biomarker Testing Revenue, 2016-2021
  6.2.2 By Region - Global Clinical Biomarker Testing Revenue, 2022-2027
  6.2.3 By Region - Global Clinical Biomarker Testing Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Clinical Biomarker Testing Revenue, 2016-2027
  6.3.2 US Clinical Biomarker Testing Market Size, 2016-2027
  6.3.3 Canada Clinical Biomarker Testing Market Size, 2016-2027
  6.3.4 Mexico Clinical Biomarker Testing Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Clinical Biomarker Testing Revenue, 2016-2027
  6.4.2 Germany Clinical Biomarker Testing Market Size, 2016-2027
  6.4.3 France Clinical Biomarker Testing Market Size, 2016-2027
  6.4.4 U.K. Clinical Biomarker Testing Market Size, 2016-2027
  6.4.5 Italy Clinical Biomarker Testing Market Size, 2016-2027
  6.4.6 Russia Clinical Biomarker Testing Market Size, 2016-2027
  6.4.7 Nordic Countries Clinical Biomarker Testing Market Size, 2016-2027
  6.4.8 Benelux Clinical Biomarker Testing Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Clinical Biomarker Testing Revenue, 2016-2027
  6.5.2 China Clinical Biomarker Testing Market Size, 2016-2027
  6.5.3 Japan Clinical Biomarker Testing Market Size, 2016-2027
  6.5.4 South Korea Clinical Biomarker Testing Market Size, 2016-2027
  6.5.5 Southeast Asia Clinical Biomarker Testing Market Size, 2016-2027
  6.5.6 India Clinical Biomarker Testing Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Clinical Biomarker Testing Revenue, 2016-2027
  6.6.2 Brazil Clinical Biomarker Testing Market Size, 2016-2027
  6.6.3 Argentina Clinical Biomarker Testing Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Clinical Biomarker Testing Revenue, 2016-2027
  6.7.2 Turkey Clinical Biomarker Testing Market Size, 2016-2027
  6.7.3 Israel Clinical Biomarker Testing Market Size, 2016-2027
  6.7.4 Saudi Arabia Clinical Biomarker Testing Market Size, 2016-2027
  6.7.5 UAE Clinical Biomarker Testing Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Abbott Laboratories
  7.1.1 Abbott Laboratories Corporate Summary
  7.1.2 Abbott Laboratories Business Overview
  7.1.3 Abbott Laboratories Clinical Biomarker Testing Major Product Offerings
  7.1.4 Abbott Laboratories Clinical Biomarker Testing Revenue in Global (2016-2021)
  7.1.5 Abbott Laboratories Key News
7.2 AbbVie Inc.
  7.2.1 AbbVie Inc. Corporate Summary
  7.2.2 AbbVie Inc. Business Overview
  7.2.3 AbbVie Inc. Clinical Biomarker Testing Major Product Offerings
  7.2.4 AbbVie Inc. Clinical Biomarker Testing Revenue in Global (2016-2021)
  7.2.5 AbbVie Inc. Key News
7.3 Adaptive Biotechnologies
  7.3.1 Adaptive Biotechnologies Corporate Summary
  7.3.2 Adaptive Biotechnologies Business Overview
  7.3.3 Adaptive Biotechnologies Clinical Biomarker Testing Major Product Offerings
  7.3.4 Adaptive Biotechnologies Clinical Biomarker Testing Revenue in Global (2016-2021)
  7.3.5 Adaptive Biotechnologies Key News
7.4 Agilent Technologies
  7.4.1 Agilent Technologies Corporate Summary
  7.4.2 Agilent Technologies Business Overview
  7.4.3 Agilent Technologies Clinical Biomarker Testing Major Product Offerings
  7.4.4 Agilent Technologies Clinical Biomarker Testing Revenue in Global (2016-2021)
  7.4.5 Agilent Technologies Key News
7.5 BD
  7.5.1 BD Corporate Summary
  7.5.2 BD Business Overview
  7.5.3 BD Clinical Biomarker Testing Major Product Offerings
  7.5.4 BD Clinical Biomarker Testing Revenue in Global (2016-2021)
  7.5.5 BD Key News
7.6 Becton Dickinson
  7.6.1 Becton Dickinson Corporate Summary
  7.6.2 Becton Dickinson Business Overview
  7.6.3 Becton Dickinson Clinical Biomarker Testing Major Product Offerings
  7.6.4 Becton Dickinson Clinical Biomarker Testing Revenue in Global (2016-2021)
  7.6.5 Becton Dickinson Key News
7.7 Bio-Rad Laboratories
  7.7.1 Bio-Rad Laboratories Corporate Summary
  7.7.2 Bio-Rad Laboratories Business Overview
  7.7.3 Bio-Rad Laboratories Clinical Biomarker Testing Major Product Offerings
  7.4.4 Bio-Rad Laboratories Clinical Biomarker Testing Revenue in Global (2016-2021)
  7.7.5 Bio-Rad Laboratories Key News
7.8 Danaher Corporation
  7.8.1 Danaher Corporation Corporate Summary
  7.8.2 Danaher Corporation Business Overview
  7.8.3 Danaher Corporation Clinical Biomarker Testing Major Product Offerings
  7.8.4 Danaher Corporation Clinical Biomarker Testing Revenue in Global (2016-2021)
  7.8.5 Danaher Corporation Key News
7.9 Merck and Co.
  7.9.1 Merck and Co. Corporate Summary
  7.9.2 Merck and Co. Business Overview
  7.9.3 Merck and Co. Clinical Biomarker Testing Major Product Offerings
  7.9.4 Merck and Co. Clinical Biomarker Testing Revenue in Global (2016-2021)
  7.9.5 Merck and Co. Key News
7.10 Thermofisher Scientific
  7.10.1 Thermofisher Scientific Corporate Summary
  7.10.2 Thermofisher Scientific Business Overview
  7.10.3 Thermofisher Scientific Clinical Biomarker Testing Major Product Offerings
  7.10.4 Thermofisher Scientific Clinical Biomarker Testing Revenue in Global (2016-2021)
  7.10.5 Thermofisher Scientific Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Clinical Biomarker Testing Market Opportunities & Trends in Global Market
Table 2. Clinical Biomarker Testing Market Drivers in Global Market
Table 3. Clinical Biomarker Testing Market Restraints in Global Market
Table 4. Key Players of Clinical Biomarker Testing in Global Market
Table 5. Top Clinical Biomarker Testing Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Clinical Biomarker Testing Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Clinical Biomarker Testing Revenue Share by Companies, 2016-2021
Table 8. Global Companies Clinical Biomarker Testing Product Type
Table 9. List of Global Tier 1 Clinical Biomarker Testing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Clinical Biomarker Testing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Clinical Biomarker Testing Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Clinical Biomarker Testing Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Clinical Biomarker Testing Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Clinical Biomarker Testing Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Clinical Biomarker Testing Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Clinical Biomarker Testing Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Clinical Biomarker Testing Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Clinical Biomarker Testing Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Clinical Biomarker Testing Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Clinical Biomarker Testing Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Clinical Biomarker Testing Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Clinical Biomarker Testing Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Clinical Biomarker Testing Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Clinical Biomarker Testing Revenue, (US$, Mn), 2022-2027
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Clinical Biomarker Testing Product Offerings
Table 32. Abbott Laboratories Clinical Biomarker Testing Revenue (US$, Mn), (2016-2021)
Table 33. AbbVie Inc. Corporate Summary
Table 34. AbbVie Inc. Clinical Biomarker Testing Product Offerings
Table 35. AbbVie Inc. Clinical Biomarker Testing Revenue (US$, Mn), (2016-2021)
Table 36. Adaptive Biotechnologies Corporate Summary
Table 37. Adaptive Biotechnologies Clinical Biomarker Testing Product Offerings
Table 38. Adaptive Biotechnologies Clinical Biomarker Testing Revenue (US$, Mn), (2016-2021)
Table 39. Agilent Technologies Corporate Summary
Table 40. Agilent Technologies Clinical Biomarker Testing Product Offerings
Table 41. Agilent Technologies Clinical Biomarker Testing Revenue (US$, Mn), (2016-2021)
Table 42. BD Corporate Summary
Table 43. BD Clinical Biomarker Testing Product Offerings
Table 44. BD Clinical Biomarker Testing Revenue (US$, Mn), (2016-2021)
Table 45. Becton Dickinson Corporate Summary
Table 46. Becton Dickinson Clinical Biomarker Testing Product Offerings
Table 47. Becton Dickinson Clinical Biomarker Testing Revenue (US$, Mn), (2016-2021)
Table 48. Bio-Rad Laboratories Corporate Summary
Table 49. Bio-Rad Laboratories Clinical Biomarker Testing Product Offerings
Table 50. Bio-Rad Laboratories Clinical Biomarker Testing Revenue (US$, Mn), (2016-2021)
Table 51. Danaher Corporation Corporate Summary
Table 52. Danaher Corporation Clinical Biomarker Testing Product Offerings
Table 53. Danaher Corporation Clinical Biomarker Testing Revenue (US$, Mn), (2016-2021)
Table 54. Merck and Co. Corporate Summary
Table 55. Merck and Co. Clinical Biomarker Testing Product Offerings
Table 56. Merck and Co. Clinical Biomarker Testing Revenue (US$, Mn), (2016-2021)
Table 57. Thermofisher Scientific Corporate Summary
Table 58. Thermofisher Scientific Clinical Biomarker Testing Product Offerings
Table 59. Thermofisher Scientific Clinical Biomarker Testing Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Clinical Biomarker Testing Segment by Type
Figure 2. Clinical Biomarker Testing Segment by Application
Figure 3. Global Clinical Biomarker Testing Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Clinical Biomarker Testing Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Clinical Biomarker Testing Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Clinical Biomarker Testing Revenue in 2020
Figure 8. By Type - Global Clinical Biomarker Testing Revenue Market Share, 2016-2027
Figure 9. By Application - Global Clinical Biomarker Testing Revenue Market Share, 2016-2027
Figure 10. By Region - Global Clinical Biomarker Testing Revenue Market Share, 2016-2027
Figure 11. By Country - North America Clinical Biomarker Testing Revenue Market Share, 2016-2027
Figure 12. US Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Clinical Biomarker Testing Revenue Market Share, 2016-2027
Figure 16. Germany Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 17. France Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Clinical Biomarker Testing Revenue Market Share, 2016-2027
Figure 24. China Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 28. India Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Clinical Biomarker Testing Revenue Market Share, 2016-2027
Figure 30. Brazil Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Clinical Biomarker Testing Revenue Market Share, 2016-2027
Figure 33. Turkey Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Clinical Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 37. Abbott Laboratories Clinical Biomarker Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. AbbVie Inc. Clinical Biomarker Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Adaptive Biotechnologies Clinical Biomarker Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Agilent Technologies Clinical Biomarker Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. BD Clinical Biomarker Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Becton Dickinson Clinical Biomarker Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Bio-Rad Laboratories Clinical Biomarker Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Danaher Corporation Clinical Biomarker Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Merck and Co. Clinical Biomarker Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications